IRIS Accounts Production v24.1.4.33 06934305 Board of Directors 1.12.22 31.5.24 31.5.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069343052022-11-30069343052024-05-31069343052022-12-012024-05-31069343052021-11-30069343052021-12-012022-11-30069343052022-11-3006934305ns15:EnglandWales2022-12-012024-05-3106934305ns14:PoundSterling2022-12-012024-05-3106934305ns10:Director12022-12-012024-05-3106934305ns10:PrivateLimitedCompanyLtd2022-12-012024-05-3106934305ns10:SmallEntities2022-12-012024-05-3106934305ns10:AuditExempt-NoAccountantsReport2022-12-012024-05-3106934305ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012024-05-3106934305ns10:SmallCompaniesRegimeForAccounts2022-12-012024-05-3106934305ns10:FullAccounts2022-12-012024-05-310693430512022-12-012024-05-3106934305ns10:OrdinaryShareClass12022-12-012024-05-3106934305ns10:Director22022-12-012024-05-3106934305ns10:RegisteredOffice2022-12-012024-05-3106934305ns5:CurrentFinancialInstruments2024-05-3106934305ns5:CurrentFinancialInstruments2022-11-3006934305ns5:ShareCapital2024-05-3106934305ns5:ShareCapital2022-11-3006934305ns5:RetainedEarningsAccumulatedLosses2024-05-3106934305ns5:RetainedEarningsAccumulatedLosses2022-11-3006934305ns5:NetGoodwill2022-12-012024-05-3106934305ns5:NetGoodwill2022-11-3006934305ns5:IntangibleAssetsOtherThanGoodwill2022-11-3006934305ns5:IntangibleAssetsOtherThanGoodwill2022-12-012024-05-3106934305ns5:NetGoodwill2024-05-3106934305ns5:IntangibleAssetsOtherThanGoodwill2024-05-3106934305ns5:NetGoodwill2022-11-3006934305ns5:IntangibleAssetsOtherThanGoodwill2022-11-3006934305ns5:LeaseholdImprovements2022-11-3006934305ns5:FurnitureFittings2022-11-3006934305ns5:MotorVehicles2022-11-3006934305ns5:ComputerEquipment2022-11-3006934305ns5:LeaseholdImprovements2022-12-012024-05-3106934305ns5:FurnitureFittings2022-12-012024-05-3106934305ns5:MotorVehicles2022-12-012024-05-3106934305ns5:ComputerEquipment2022-12-012024-05-3106934305ns5:LeaseholdImprovements2024-05-3106934305ns5:FurnitureFittings2024-05-3106934305ns5:MotorVehicles2024-05-3106934305ns5:ComputerEquipment2024-05-3106934305ns5:LeaseholdImprovements2022-11-3006934305ns5:FurnitureFittings2022-11-3006934305ns5:MotorVehicles2022-11-3006934305ns5:ComputerEquipment2022-11-3006934305ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-05-3106934305ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-3006934305ns10:OrdinaryShareClass12024-05-31
REGISTERED NUMBER: 06934305 (England and Wales)


















MILLER MEDICAL SUPPLIES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024






MILLER MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 06934305)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MILLER MEDICAL SUPPLIES LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024







DIRECTORS: Mrs R E Bassett
Mr M E Bassett





REGISTERED OFFICE: Unit 3 Stephenson Street
Industrial Estate
Newport
NP19 4XB





REGISTERED NUMBER: 06934305 (England and Wales)





ACCOUNTANTS: MHA (trading name of MacIntyre Hudson LLP)
Limited liability partnership in England & Wales
Registered number OC312313
Elfed House
Oak Tree Court
Cardiff Gate Business Park
CARDIFF
County of Cardiff
CF23 8RS

MILLER MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 06934305)

BALANCE SHEET
31 MAY 2024

2024 2022
Notes £    £   
FIXED ASSETS
Intangible assets 4 5,810 7,736
Tangible assets 5 75,159 51,645
80,969 59,381

CURRENT ASSETS
Stocks 110,000 135,000
Debtors 6 113,989 190,119
Cash at bank 443,095 330,426
667,084 655,545
CREDITORS
Amounts falling due within one year 7 (210,906 ) (193,792 )
NET CURRENT ASSETS 456,178 461,753
TOTAL ASSETS LESS CURRENT
LIABILITIES

537,147

521,134

PROVISIONS FOR LIABILITIES (9,302 ) (1,953 )
NET ASSETS 527,845 519,181

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 526,845 518,181
SHAREHOLDERS' FUNDS 527,845 519,181

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved for issue by the Board of Directors and authorised for issue on 21 March 2025 and were signed on its behalf by:




Mr M E Bassett - Director


MILLER MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 06934305)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024


1. STATUTORY INFORMATION

Miller Medical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in Sterling (£), the company's functional currency, and rounded to the nearest pound.

The significant accounting policies applied in the presentation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

There have been no material departures from Financial Reporting Standard 102 1A.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount transferred across to the company on incorporation, has been fully written off.

Tangible fixed assets
Tangible fixed assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible fixed assets, less their estimated residual value, over the expected useful lives as follows:-

Freehold propertyStraight line over 20 years
Fixtures, fittings and equipment25% reducing balance
Motor vehicles25% reducing balance

The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Current tax
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that have occurred at that date will result in an obligation to pay more, or a right to pay less or to receive more tax.

Deferred tax assets are recognised only to the extent that the directors consider that it is more likely that not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

Deferred tax is measured on an un-discounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

MILLER MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 06934305)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024


2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Cash and cash equivalents
Cash and cash equivalents in the balance sheet comprise cash at bank and in hand.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 9 (2022 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 December 2022
and 31 May 2024 162,000 10,270 172,270
AMORTISATION
At 1 December 2022 162,000 2,534 164,534
Charge for period - 1,926 1,926
At 31 May 2024 162,000 4,460 166,460
NET BOOK VALUE
At 31 May 2024 - 5,810 5,810
At 30 November 2022 - 7,736 7,736

5. TANGIBLE FIXED ASSETS
Improvements Fixtures,
to fittings Motor Computer
property & equipment vehicles equipment Totals
£    £    £    £    £   
COST
At 1 December 2022 46,776 101,257 31,080 - 179,113
Additions - 2,180 - 44,220 46,400
Disposals - - (16,080 ) - (16,080 )
At 31 May 2024 46,776 103,437 15,000 44,220 209,433
DEPRECIATION
At 1 December 2022 2,872 95,227 29,369 - 127,468
Charge for period 7,022 3,871 259 11,055 22,207
Eliminated on disposal - - (15,401 ) - (15,401 )
At 31 May 2024 9,894 99,098 14,227 11,055 134,274
NET BOOK VALUE
At 31 May 2024 36,882 4,339 773 33,165 75,159
At 30 November 2022 43,904 6,030 1,711 - 51,645

MILLER MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 06934305)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 DECEMBER 2022 TO 31 MAY 2024


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2022
£    £   
Trade debtors 105,604 168,594
Other debtors 8,385 8,154
VAT - 13,371
113,989 190,119

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2022
£    £   
Trade creditors 125,051 148,148
Amounts owed to associates 5,022 -
Corporation tax - 209
Social security and other taxes 9,104 -
VAT 29,779 -
Other creditors 1,069 -
Directors' current accounts 218 692
Accruals and deferred income 40,663 44,743
210,906 193,792

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2022
value: £    £   
1,000 Ordinary £1 1,000 1,000